Sign in to edit your profile (add interests, mentoring, photo, etc.)

    Emmanuelle Passegue, PhD

    TitleProfessor
    SchoolUCSF School of Medicine
    DepartmentMedicine
    Address35 Medical Center Way, RMB-
    San Francisco CA 94143
    Phone415-476-2426

       ORNG Applications 
       In The News
       NIH Awarded Grants
       More Info

       Bibliographic 
       Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Kohli L, Passegué E. Surviving change: the metabolic journey of hematopoietic stem cells. Trends Cell Biol. 2014 Aug; 24(8):479-87.
        View in: PubMed
      2. Pietras EM, Lakshminarasimhan R, Techner JM, Fong S, Flach J, Binnewies M, Passegué E. Re-entry into quiescence protects hematopoietic stem cells from the killing effect of chronic exposure to type I interferons. J Exp Med. 2014 Feb 10; 211(2):245-62.
        View in: PubMed
      3. Bakker ST, Passegué E. Resilient and resourceful: Genome maintenance strategies in hematopoietic stem cells. Exp Hematol. 2013 Nov; 41(11):915-23.
        View in: PubMed
      4. Pietras EM, Passegué E. Linking HSCs to their youth. Nat Cell Biol. 2013 Aug; 15(8):885-7.
        View in: PubMed
      5. Schepers K, Pietras EM, Reynaud D, Flach J, Binnewies M, Garg T, Wagers AJ, Hsiao EC, Passegué E. Myeloproliferative neoplasia remodels the endosteal bone marrow niche into a self-reinforcing leukemic niche. Cell Stem Cell. 2013 Sep 5; 13(3):285-99.
        View in: PubMed
      6. Warr MR, Kohli L, Passegué E. Born to survive: autophagy in hematopoietic stem cell maintenance. Cell Cycle. 2013 Jul 1; 12(13):1979-80.
        View in: PubMed
      7. Warr MR, Binnewies M, Flach J, Reynaud D, Garg T, Malhotra R, Debnath J, Passegué E. FOXO3A directs a protective autophagy program in haematopoietic stem cells. Nature. 2013 Feb 21; 494(7437):323-7.
        View in: PubMed
      8. Li M, Jones L, Gaillard C, Binnewies M, Ochoa R, Garcia E, Lam V, Wei G, Yang W, Lobe C, Hermiston M, Passegué E, Kogan SC. Initially disadvantaged, TEL-AML1 cells expand and initiate leukemia in response to irradiation and cooperating mutations. Leukemia. 2013 Jul; 27(7):1570-3.
        View in: PubMed
      9. Warr MR, Passegué E. Metabolic makeover for HSCs. Cell Stem Cell. 2013 Jan 3; 12(1):1-3.
        View in: PubMed
      10. Schepers K, Hsiao EC, Garg T, Scott MJ, Passegué E. Activated Gs signaling in osteoblastic cells alters the hematopoietic stem cell niche in mice. Blood. 2012 Oct 25; 120(17):3425-35.
        View in: PubMed
      11. Blanpain C, Daley GQ, Hochedlinger K, Passegué E, Rossant J, Yamanaka S. Stem cells assessed. Nat Rev Mol Cell Biol. 2012 Jul; 13(7):471-6.
        View in: PubMed
      12. Smith-Berdan S, Schepers K, Ly A, Passegué E, Forsberg EC. Dynamic expression of the Robo ligand Slit2 in bone marrow cell populations. Cell Cycle. 2012 Feb 15; 11(4):675-82.
        View in: PubMed
      13. Pietras EM, Warr MR, Passegué E. Cell cycle regulation in hematopoietic stem cells. J Cell Biol. 2011 Nov 28; 195(5):709-20.
        View in: PubMed
      14. Reynaud D, Pietras E, Barry-Holson K, Mir A, Binnewies M, Jeanne M, Sala-Torra O, Radich JP, Passegué E. IL-6 controls leukemic multipotent progenitor cell fate and contributes to chronic myelogenous leukemia development. Cancer Cell. 2011 Nov 15; 20(5):661-73.
        View in: PubMed
      15. Garcia D, Warr MR, Martins CP, Brown Swigart L, Passegué E, Evan GI. Validation of MdmX as a therapeutic target for reactivating p53 in tumors. Genes Dev. 2011 Aug 15; 25(16):1746-57.
        View in: PubMed
      16. Warr MR, Pietras EM, Passegué E. Mechanisms controlling hematopoietic stem cell functions during normal hematopoiesis and hematological malignancies. Wiley Interdiscip Rev Syst Biol Med. 2011 Nov-Dec; 3(6):681-701.
        View in: PubMed
      17. Blanpain C, Mohrin M, Sotiropoulou PA, Passegué E. DNA-damage response in tissue-specific and cancer stem cells. Cell Stem Cell. 2011 Jan 7; 8(1):16-29.
        View in: PubMed
      18. Elefanty AG, Blelloch R, Passegué E, Wernig M, Mummery CL. On the streets of San Francisco: highlights from the ISSCR Annual Meeting 2010. Cell Stem Cell. 2010 Oct 8; 7(4):443-50.
        View in: PubMed
      19. Subramanyam D, Belair CD, Barry-Holson KQ, Lin H, Kogan SC, Passegué E, Blelloch R. PML-RAR{alpha} and Dnmt3a1 cooperate in vivo to promote acute promyelocytic leukemia. Cancer Res. 2010 Nov 1; 70(21):8792-801.
        View in: PubMed
      20. Ragu C, Elain G, Mylonas E, Ottolenghi C, Cagnard N, Daegelen D, Passegué E, Vainchenker W, Bernard OA, Penard-Lacronique V. The transcription factor Srf regulates hematopoietic stem cell adhesion. Blood. 2010 Nov 25; 116(22):4464-73.
        View in: PubMed
      21. Mohrin M, Bourke E, Alexander D, Warr MR, Barry-Holson K, Le Beau MM, Morrison CG, Passegué E. Hematopoietic stem cell quiescence promotes error-prone DNA repair and mutagenesis. Cell Stem Cell. 2010 Aug 6; 7(2):174-85.
        View in: PubMed
      22. Forsberg EC, Passegué E, Prohaska SS, Wagers AJ, Koeva M, Stuart JM, Weissman IL. Molecular signatures of quiescent, mobilized and leukemia-initiating hematopoietic stem cells. PLoS One. 2010; 5(1):e8785.
        View in: PubMed
      23. Passegué E, Ernst P. IFN-alpha wakes up sleeping hematopoietic stem cells. Nat Med. 2009 Jun; 15(6):612-3.
        View in: PubMed
      24. Santaguida M, Schepers K, King B, Sabnis AJ, Forsberg EC, Attema JL, Braun BS, Passegué E. JunB protects against myeloid malignancies by limiting hematopoietic stem cell proliferation and differentiation without affecting self-renewal. Cancer Cell. 2009 Apr 7; 15(4):341-52.
        View in: PubMed
      25. Sabnis AJ, Cheung LS, Dail M, Kang HC, Santaguida M, Hermiston ML, Passegué E, Shannon K, Braun BS. Oncogenic Kras initiates leukemia in hematopoietic stem cells. PLoS Biol. 2009 Mar 17; 7(3):e59.
        View in: PubMed
      26. Passegué E, Rafii S, Herlyn M. Cancer stem cells are everywhere. Nat Med. 2009 Jan; 15(1):23.
        View in: PubMed
      27. Viatour P, Somervaille TC, Venkatasubrahmanyam S, Kogan S, McLaughlin ME, Weissman IL, Butte AJ, Passegué E, Sage J. Hematopoietic stem cell quiescence is maintained by compound contributions of the retinoblastoma gene family. Cell Stem Cell. 2008 Oct 9; 3(4):416-28.
        View in: PubMed
      28. Shen WF, Hu YL, Uttarwar L, Passegue E, Largman C. MicroRNA-126 regulates HOXA9 by binding to the homeobox. Mol Cell Biol. 2008 Jul; 28(14):4609-19.
        View in: PubMed
      29. Min IM, Pietramaggiori G, Kim FS, Passegué E, Stevenson KE, Wagers AJ. The transcription factor EGR1 controls both the proliferation and localization of hematopoietic stem cells. Cell Stem Cell. 2008 Apr 10; 2(4):380-91.
        View in: PubMed
      30. Du R, Lu KV, Petritsch C, Liu P, Ganss R, Passegué E, Song H, Vandenberg S, Johnson RS, Werb Z, Bergers G. HIF1alpha induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion. Cancer Cell. 2008 Mar; 13(3):206-20.
        View in: PubMed
      31. Rajasekhar VK, Dalerba P, Passegué E, Lagasse E, Najbauer J. The 5th International Society for Stem Cell Research (ISSCR) Annual Meeting, June 2007. Stem Cells. 2008 Jan; 26(1):292-8.
        View in: PubMed
      32. Hu YL, Passegué E, Fong S, Largman C, Lawrence HJ. Evidence that the Pim1 kinase gene is a direct target of HOXA9. Blood. 2007 Jun 1; 109(11):4732-8.
        View in: PubMed
      33. Tothova Z, Kollipara R, Huntly BJ, Lee BH, Castrillon DH, Cullen DE, McDowell EP, Lazo-Kallanian S, Williams IR, Sears C, Armstrong SA, Passegué E, DePinho RA, Gilliland DG. FoxOs are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stress. Cell. 2007 Jan 26; 128(2):325-39.
        View in: PubMed
      34. Van Meter ME, Díaz-Flores E, Archard JA, Passegué E, Irish JM, Kotecha N, Nolan GP, Shannon K, Braun BS. K-RasG12D expression induces hyperproliferation and aberrant signaling in primary hematopoietic stem/progenitor cells. Blood. 2007 May 1; 109(9):3945-52.
        View in: PubMed
      35. Giuriato S, Ryeom S, Fan AC, Bachireddy P, Lynch RC, Rioth MJ, van Riggelen J, Kopelman AM, Passegué E, Tang F, Folkman J, Felsher DW. Sustained regression of tumors upon MYC inactivation requires p53 or thrombospondin-1 to reverse the angiogenic switch. Proc Natl Acad Sci U S A. 2006 Oct 31; 103(44):16266-71.
        View in: PubMed
      36. Steidl U, Rosenbauer F, Verhaak RG, Gu X, Ebralidze A, Otu HH, Klippel S, Steidl C, Bruns I, Costa DB, Wagner K, Aivado M, Kobbe G, Valk PJ, Passegué E, Libermann TA, Delwel R, Tenen DG. Essential role of Jun family transcription factors in PU.1 knockdown-induced leukemic stem cells. Nat Genet. 2006 Nov; 38(11):1269-77.
        View in: PubMed
      37. Passegué E. Cancer biology: a game of subversion. Nature. 2006 Aug 17; 442(7104):754-5.
        View in: PubMed
      38. Forsberg EC, Serwold T, Kogan S, Weissman IL, Passegué E. New evidence supporting megakaryocyte-erythrocyte potential of flk2/flt3+ multipotent hematopoietic progenitors. Cell. 2006 Jul 28; 126(2):415-26.
        View in: PubMed
      39. Nyholm SV, Passegue E, Ludington WB, Voskoboynik A, Mitchel K, Weissman IL, De Tomaso AW. fester, A candidate allorecognition receptor from a primitive chordate. Immunity. 2006 Jul; 25(1):163-73.
        View in: PubMed
      40. Passegué E, Wagers AJ. Regulating quiescence: new insights into hematopoietic stem cell biology. Dev Cell. 2006 Apr; 10(4):415-7.
        View in: PubMed
      41. Passegué E, Wagers AJ, Giuriato S, Anderson WC, Weissman IL. Global analysis of proliferation and cell cycle gene expression in the regulation of hematopoietic stem and progenitor cell fates. J Exp Med. 2005 Dec 5; 202(11):1599-611.
        View in: PubMed
      42. Passegué E. Hematopoietic stem cells, leukemic stem cells and chronic myelogenous leukemia. Cell Cycle. 2005 Feb; 4(2):266-8.
        View in: PubMed
      43. Passegué E, Weisman IL. Leukemic stem cells: where do they come from? Stem Cell Rev. 2005; 1(3):181-8.
        View in: PubMed
      44. Jamieson CH, Weissman IL, Passegué E. Chronic versus acute myelogenous leukemia: a question of self-renewal. Cancer Cell. 2004 Dec; 6(6):531-3.
        View in: PubMed
      45. Passegué E, Wagner EF, Weissman IL. JunB deficiency leads to a myeloproliferative disorder arising from hematopoietic stem cells. Cell. 2004 Oct 29; 119(3):431-43.
        View in: PubMed
      46. Cozzio A, Passegué E, Ayton PM, Karsunky H, Cleary ML, Weissman IL. Similar MLL-associated leukemias arising from self-renewing stem cells and short-lived myeloid progenitors. Genes Dev. 2003 Dec 15; 17(24):3029-35.
        View in: PubMed
      47. Passegué E, Jamieson CH, Ailles LE, Weissman IL. Normal and leukemic hematopoiesis: are leukemias a stem cell disorder or a reacquisition of stem cell characteristics? Proc Natl Acad Sci U S A. 2003 Sep 30; 100 Suppl 1:11842-9.
        View in: PubMed
      48. Szremska AP, Kenner L, Weisz E, Ott RG, Passegué E, Artwohl M, Freissmuth M, Stoxreiter R, Theussl HC, Parzer SB, Moriggl R, Wagner EF, Sexl V. JunB inhibits proliferation and transformation in B-lymphoid cells. Blood. 2003 Dec 1; 102(12):4159-65.
        View in: PubMed
      49. So CW, Karsunky H, Passegué E, Cozzio A, Weissman IL, Cleary ML. MLL-GAS7 transforms multipotent hematopoietic progenitors and induces mixed lineage leukemias in mice. Cancer Cell. 2003 Feb; 3(2):161-71.
        View in: PubMed
      50. Passegué E, Jochum W, Behrens A, Ricci R, Wagner EF. JunB can substitute for Jun in mouse development and cell proliferation. Nat Genet. 2002 Feb; 30(2):158-66.
        View in: PubMed
      51. Jochum W, Passegué E, Wagner EF. AP-1 in mouse development and tumorigenesis. Oncogene. 2001 Apr 30; 20(19):2401-12.
        View in: PubMed
      52. Passegué E, Jochum W, Schorpp-Kistner M, Möhle-Steinlein U, Wagner EF. Chronic myeloid leukemia with increased granulocyte progenitors in mice lacking junB expression in the myeloid lineage. Cell. 2001 Jan 12; 104(1):21-32.
        View in: PubMed
      53. Passegué E, Wagner EF. JunB suppresses cell proliferation by transcriptional activation of p16(INK4a) expression. EMBO J. 2000 Jun 15; 19(12):2969-79.
        View in: PubMed
      54. Jochum W, Passegue E, Wagner EF. [Loss of junB expression causes a myeloproliferative syndrome resembling chronic myeloid leukemia]. Verh Dtsch Ges Pathol. 1999; 83:216-7.
        View in: PubMed
      55. Passegue E, Richard JL, Boulla G, Gourdji D. Multiple intracellular signallings are involved in thyrotropin-releasing hormone (TRH)-induced c-fos and jun B mRNA levels in clonal prolactin cells. Mol Cell Endocrinol. 1995 Jan; 107(1):29-40.
        View in: PubMed
      56. Passegué E, Laverrière JN, Boulla G, Gourdji D. [Stimulation of C-fos and jun B proto-oncogenes: potential role of TRH effects in clone cell line with prolactin (GH3B6)]. C R Seances Soc Biol Fil. 1995; 189(1):97-110.
        View in: PubMed
      57. Passegue E, Laverriere JN, Gourdji D. Thyrotropin-releasing hormone stimulates in parallel jun B and c-fos messenger ribonucleic acids in GH3B6 pituitary cells: comparison with PRL secretion. Mol Cell Neurosci. 1994 Apr; 5(2):109-18.
        View in: PubMed
      58. Gourdji D, Laverriere JN, Passegué E, Richard JL. Hypophyseal cells model systems: the "GH" rat tumor-derived cell lines as a tool for the study of gene expression. Cell Biol Toxicol. 1992 Jul-Sep; 8(3):29-38.
        View in: PubMed
      Emmanuelle's Networks
      Related Concepts
      Derived automatically from this person's publications.
      _
      Co-Authors
      People in Profiles who have published with this person.
      _
      Related Authors
      People who share related concepts with this person.
      _
      Back to TOP